Physician profile
Snesha Modi
NPI 1366616435
$3,993.81
in general payments reported to CMS, 2019-2025
33 companies · $683 in 2025
The $683 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $183 · 2021: $603 · 2022: $380 · 2023: $956 · 2024: $743 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,383.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $785.94 | 2021-2025 | |
| Glaxosmithkline, LLC. | $547.56 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $476.06 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $278.92 | 2019-2025 | Evenity, Prolia, Prolia |
| Merck Sharp & Dohme LLC | $235.81 | 2019-2024 | Verquvo, Belsomra, Steglatro |
| Lilly USA, LLC | $176.82 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $147.71 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $137.83 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.20 | 2019-2024 | Jardiance |
| Travere Therapeutics, INC. | $124.99 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $94.52 | 2023-2024 | Camzyos, Eliquis |
| Pfizer INC. | $86.74 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $75.09 | 2019-2022 | |
| Amarin Pharma, INC. | $73.01 | 2019-2021 | |
| Mylan Specialty L.P. | $62.57 | 2024 | Yupelri |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $57.82 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.05 | 2019-2022 | |
| Exact Sciences Corporation | $47.57 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $46.95 | 2023-2024 | Gemtesa |
| Corium, LLC | $43.36 | 2023-2024 | Azstarys |
| Sunovion Pharmaceuticals INC. | $39.24 | 2021-2022 | |
| Boston Scientific Corporation | $35.06 | 2025 | Watchman Flx |
| Otsuka America Pharmaceutical, INC. | $35.01 | 2024-2025 | Rexulti |
| Inspire Medical Systems, INC. | $34.30 | 2024-2025 | Inspire |
| Allergan, INC. | $33.58 | 2019 | |
| Xeris Pharmaceuticals, INC. | $24.24 | 2023 | Gvoke Hypopen |
| Biohaven Pharmaceutical Holding Company LTD. | $20.77 | 2022 | |
| Abbott Laboratories | $19.76 | 2022 | |
| Esperion Therapeutics, INC. | $15.14 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.11 | 2024 | Caplyta |
| Dexcom, INC. | $15.07 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.78 | 2019 | |
| Eisai INC. | $13.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Snesha Modi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.